CABRINI, Giulio
 Distribuzione geografica
Continente #
EU - Europa 4.417
NA - Nord America 2.010
AS - Asia 1.329
SA - Sud America 224
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 27
OC - Oceania 1
Totale 8.093
Nazione #
FI - Finlandia 3.759
US - Stati Uniti d'America 1.939
SG - Singapore 451
CN - Cina 295
IT - Italia 264
VN - Vietnam 187
BR - Brasile 172
HK - Hong Kong 125
DE - Germania 92
PL - Polonia 58
GB - Regno Unito 49
ID - Indonesia 46
JP - Giappone 44
TR - Turchia 42
CA - Canada 39
SE - Svezia 39
FR - Francia 35
BD - Bangladesh 29
RU - Federazione Russa 29
UA - Ucraina 29
IN - India 27
MX - Messico 25
NL - Olanda 22
AR - Argentina 19
TH - Thailandia 16
IQ - Iraq 15
PH - Filippine 10
UZ - Uzbekistan 10
ES - Italia 9
ZA - Sudafrica 9
CO - Colombia 8
MY - Malesia 7
VE - Venezuela 6
BE - Belgio 5
EC - Ecuador 5
PK - Pakistan 5
SA - Arabia Saudita 5
CL - Cile 4
MA - Marocco 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IE - Irlanda 3
JO - Giordania 3
LT - Lituania 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AT - Austria 2
DZ - Algeria 2
IR - Iran 2
KR - Corea 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MG - Madagascar 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 8.008
Città #
Helsinki 3.735
Singapore 304
Ashburn 292
San Jose 175
Fairfield 126
Hong Kong 124
Beijing 117
Woodbridge 110
Santa Clara 106
Ferrara 102
Los Angeles 82
Chandler 73
Houston 67
Ho Chi Minh City 63
Dallas 59
Warsaw 56
Wilmington 48
Cambridge 46
Seattle 45
Munich 44
Tokyo 44
Jakarta 41
Hanoi 38
Council Bluffs 37
New York 33
Ann Arbor 32
Jacksonville 30
Shanghai 26
Lauterbourg 23
São Paulo 22
Buffalo 20
Izmir 19
Addison 18
Milan 18
Princeton 17
Turku 17
Atlanta 15
Bangkok 15
Brooklyn 15
Mexico City 14
Toronto 14
Chicago 12
Phoenix 12
Bologna 11
Denver 11
London 11
Montreal 11
Nanjing 11
Washington 11
Chennai 10
Frankfurt am Main 10
Boardman 9
Orem 9
Tashkent 9
Ankara 8
Bremen 8
Poplar 8
Rio de Janeiro 8
Shenyang 8
Dong Ket 7
Stockholm 7
Da Nang 6
Kuala Selangor 6
Moscow 6
Mountain View 6
Nuremberg 6
Padova 6
Querétaro 6
San Diego 6
San Francisco 6
The Dalles 6
Tianjin 6
Amsterdam 5
Baghdad 5
Biên Hòa 5
Haiphong 5
Hebei 5
Hefei 5
Venice 5
Assago 4
Boston 4
Brasília 4
Changsha 4
Dearborn 4
Dhaka 4
Ferrara di Monte Baldo 4
Jiaxing 4
Johannesburg 4
Manchester 4
Manila 4
Nanchang 4
Naples 4
Vũng Tàu 4
Bogotá 3
Brussels 3
Burlingame 3
Bắc Ninh 3
Bến Tre 3
Campinas 3
Can Tho 3
Totale 6.651
Nome #
A new method for measuring local ATP release at the extracellular surface of live intact cells 2.081
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.022
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 275
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 248
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 239
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 238
Anti-inflammatory activity of novel 4,6,4’-trimethylangelicin’s analogues: effects on the NF-kB activity and IL-8 expression in Cystic Fibrosis IB3-1 cells 236
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 232
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 189
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 178
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 172
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 172
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib 171
Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis 161
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 158
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 149
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 141
Mitochondrial Ca2+-dependent inflammasome activation exacerbates the P. aeruginosa-driven inflammatory response 137
miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases 126
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 116
CFTR Modulators and Reduction of Airway Inflammation in Cystic Fibrosis: How Much is Enough? 102
Overview of CF lung pathophysiology 96
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients 90
Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis 85
Revealing the microRNA-transcription factors network in cystic fibrosis:from microRNA therapeutics to precision medicine (CF-miRNA-THER) FFC 7/2018 82
Evaluation of hyaluronic acid derivates as new anti-inflammatory treatments for cystic fibrosis 58
Hyaluronic acid derivates as new potential anti-inflammatory agents for Cystic Fibrosis lung disease 54
GY971, a new anti-inflammatory agent for the treatment of Cystic Fibrosis lung disease 53
Pre-clinical validation of GY971, a new anti-inflammatory agent targeting Nuclear Factor kappa B (NF-kB) 32
Totale 8.093
Categoria #
all - tutte 25.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022191 9 8 18 6 9 8 21 13 13 12 25 49
2022/2023191 21 34 4 19 22 14 25 10 16 1 14 11
2023/2024260 13 20 16 3 64 45 9 21 4 3 6 56
2024/2025731 23 29 74 52 75 52 26 39 96 62 102 101
2025/20265.858 204 67 150 220 311 192 293 117 3.954 227 86 37
2026/202757 57 0 0 0 0 0 0 0 0 0 0 0
Totale 8.093